CEA (Carcinoembryonic Antigen): What Elevated Levels Really Mean
CEA is best known for colorectal cancer surveillance — but it is raised by smoking, inflammation and many other cancers. Learn who should test, what a high value really means, and when trending matters more than the absolute number.

Normal CEA is below 3 ng/mL in non-smokers and below 5 ng/mL in smokers. CEA is used primarily to monitor treated colorectal cancer for recurrence — a rising trend triggers imaging. Many benign conditions (smoking, chronic bronchitis, cirrhosis, IBD, pancreatitis, benign breast disease) raise it modestly. CEA is NOT a screening test.
CEA (carcinoembryonic antigen) is a glycoprotein normally expressed in fetal gut tissue and re-expressed by some adult tumours — most notably colorectal, but also pancreatic, gastric, breast, lung and medullary thyroid. Smoking chronically raises CEA. Its main validated role is monitoring for colorectal cancer recurrence after curative resection: baseline CEA before surgery, then every 3–6 months for 3 years, then every 6 months to 5 years. A rising trend prompts imaging even if the absolute value is within the reference range. CEA is NOT a screening test in average-risk populations — poor sensitivity for early disease and many false positives.
- Normal (non-smoker)
- < 3 ng/mL
- Normal (smoker)
- < 5 ng/mL
- Main clinical role
- Colorectal cancer follow-up
- Screening role
- None in average-risk population
- Trending value
- Rising CEA more meaningful than any single number
What raises CEA outside cancer
Smoking is the most common non-cancer cause of raised CEA — smokers typically sit at 2–5 ng/mL. Cirrhosis, chronic hepatitis, IBD flare, chronic bronchitis, benign breast disease, and any recent inflammation can push CEA up 1–5 ng/mL. Values above 10 ng/mL are less commonly benign and warrant investigation.
CEA thresholds and typical interpretation
| CEA (ng/mL) | Non-smoker | Smoker |
|---|---|---|
| < 3 | Normal | Normal |
| 3 – 5 | Investigate cause | Usually smoking-related |
| 5 – 10 | Investigate for cancer or chronic inflammation | Investigate if persistent |
| > 10 | High suspicion for malignancy or ongoing significant pathology | Same |
How CEA is used in colorectal cancer
Pre-operative CEA is prognostic — values above 5 ng/mL before surgery predict poorer disease-free survival. Post-operative surveillance uses serial CEA every 3–6 months for the first 3 years, then every 6 months to 5 years. A rise of ≥ 30% within 30 days OR a doubling within any period is a strong signal for recurrence — even below the reference range. Imaging (CT chest/abdomen/pelvis) is then indicated.
CEA is NOT recommended in the primary diagnosis of colorectal cancer — sensitivity is too low (only ~30% for stage I disease). It is a follow-up tool, not a screening test.
Other tumours that raise CEA
Pancreatic, gastric, breast, lung (especially non-small-cell), medullary thyroid and mucinous ovarian cancers can all raise CEA. Modestly high CEA in a patient without colorectal cancer history should trigger clinical review, not immediate cancer workup — many cases turn out to be smoking, chronic inflammation, or benign disease.
- Rising CEA during colorectal cancer follow-up — imaging for recurrence.
- CEA > 10 ng/mL in a non-smoker without known cancer — review for GI, breast, lung, or thyroid cancer.
- CEA rise + new symptoms (weight loss, abdominal pain, jaundice) — urgent workup.
- CEA rise + rising alkaline phosphatase — suspect liver metastases.
CEA interpretation walk-through
- 1Screening in an asymptomatic patient?Not recommended. Low sensitivity for early disease and many false positives.
- 2Post-colorectal-resection follow-up?Serial CEA every 3–6 months for 3 years, then every 6 months to 5 years. Rising trend prompts imaging.
- 3Isolated raised CEA, no known cancer, non-smoker?Look for cirrhosis, chronic hepatitis, IBD, chronic bronchitis. If unexplained and persistent, consider colonoscopy and imaging based on symptoms.
- 4Rising CEA below reference range?Trend still matters — repeat at 4–6 weeks; if continued rise, image.
Related questions people ask
- What is a tumour marker?
- Does smoking raise CEA?
- How is CEA used after colorectal cancer surgery?
- What is the CA 125 test?
- What is a normal CEA?
- Does IBD affect CEA?
- How does CEA relate to liver enzymes?
Frequently asked questions
- CEA < 3 non-smoker, < 5 smoker.
- Not a screening test.
- Main use: colorectal cancer follow-up.
- Trend matters more than absolute number.
- Many benign conditions raise CEA — smoking, cirrhosis, IBD.
- Values > 10 ng/mL in non-smokers usually warrant investigation.
References
3 sources- ASCOColorectal Cancer Surveillance Guidelines
US oncology surveillance framework.
ascopubs.org
- ESMOLocalised Colon Cancer: Clinical Practice Guidelines
European colorectal follow-up.
esmo.org
- NICE NG151Colorectal cancer
UK colorectal cancer management.
nice.org.uk
Related articles
Laboratory TestsTSH Test: Normal Range, High, Low & What Your Result Actually Means
TSH is the single most important thyroid number. Understand normal ranges by age and pregnancy, what a high or low value really tells you, and the two follow-up tests that clinch the diagnosis.
Laboratory TestsHbA1c Test: Normal Range, Prediabetic, Diabetic Cut-offs & How to Lower It
HbA1c reflects your average blood sugar over ~3 months. Understand every threshold — normal, prediabetes, diabetes — and the realistic actions that move the number.
Laboratory TestsLDL Cholesterol: Optimal Numbers, High Numbers, and How to Read Yours
LDL is the "bad" cholesterol only if you leave the story there. Understand optimal targets by risk group, the ApoB perspective, and the interventions that actually shift the number.